Merrimack Income Statement Research
| MACK Stock | USD 14.73 0.02 0.14% |
Merrimack |
Most accounts from Merrimack Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Merrimack Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Merrimack Pharmaceuticals Valuation and Merrimack Pharmaceuticals Correlation analysis. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.At this time, Merrimack Pharmaceuticals' Total Revenue is quite stable compared to the past year. Total Other Income Expense Net is expected to rise to about 1.1 M this year, although the value of Gross Profit is projected to rise to (486.2 K).
| 2023 | 2024 (projected) | Total Operating Expenses | 2.2M | 2.1M | Cost Of Revenue | 400.5K | 380.5K |
Merrimack Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Merrimack Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merrimack Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 1.5M | 141K | 20K | (188K) | (169.2K) | (160.7K) | |
| Gross Profit | (67.3M) | (49.0M) | (2.2M) | (445K) | (511.8K) | (486.2K) | |
| Operating Income | (22.4M) | (2.9M) | (2.5M) | (1.7M) | (2.2M) | (2.3M) | |
| Ebit | (22.4M) | (2.9M) | (2.5M) | (1.7M) | (2.2M) | (2.3M) | |
| Ebitda | (23.9M) | (5.2M) | (2.8M) | (2.6M) | (2.2M) | (2.3M) | |
| Cost Of Revenue | 67.3M | 49.0M | 2.2M | 445K | 400.5K | 380.5K | |
| Income Before Tax | (22.7M) | (3.0M) | (2.5M) | (1.5M) | (1.2M) | (1.2M) | |
| Net Income | (21.3M) | (3.0M) | (2.5M) | (1.5M) | (1.2M) | (1.2M) | |
| Income Tax Expense | (7.7M) | (1.5M) | 14K | 3K | 12K | 12.6K | |
| Tax Provision | (7.7M) | (1.5M) | 14K | 3K | 12K | 12.6K | |
| Interest Income | 777K | 50K | 20K | 188K | 724K | 687.8K | |
| Net Interest Income | (751K) | 50K | 20K | 188K | 724K | 760.2K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Merrimack Pharmaceuticals Valuation and Merrimack Pharmaceuticals Correlation analysis. For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Merrimack Stock analysis
When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.08) | Return On Assets (0.07) | Return On Equity (0.06) |
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.